Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Indian Journal of Surgical Oncology
Published in: Indian Journal of Surgical Oncology 1/2022

01-03-2022 | Thyroidectomy | Review Article

Revision Thyroid Surgery

Authors: Karthik Nagaraja Rao, Satish Satpute, Nitin M. Nagarkar, Ambesh Singh

Published in: Indian Journal of Surgical Oncology | Issue 1/2022

Login to get access

Abstract

The incidence of recurrence in well-differentiated thyroid malignancies range from 10 to 30%. It is estimated that about 31–46% of patients with differentiated thyroid cancer will have the persistent disease and 1.2–6.8% will have structural recurrences during post-operative monitoring, depending on the initial therapy and prognostic variables. It is challenging to decide on treatment versus active monitoring following repeated or persistent tumour detection. The biological factors of the tumour and the patient guide us in the overall decision-making. Revision thyroid surgery is technically challenging. The morbidity encountered during the revision surgery is related to the anatomy of the region undergoing dissection, the degree of fibrosis and scarring from prior surgery and the operating surgeon’s experience. Successful comprehensive management of revision thyroid surgery needs a multi-disciplinary approach. This review article highlights the definition, indications for revision surgery, identification of recurrent disease, management of parathyroid and recurrent laryngeal nerves with neuromonitoring.
Literature
1.
Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418–428PubMedCrossRef
2.
Hugo J, Robenshtok E, Grewal R, Larson S, Tuttle RM (2012) Recombinant human thyroid stimulating hormone–assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence. Thyroid 22(10):1007–15
3.
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133PubMedPubMedCentralCrossRef
4.
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid Off J Am Thyroid Assoc. 2009;19(11):1167–214.
5.
Pitoia F, Jerkovich F (2019) Dynamic risk assessment in patients with differentiated thyroid cancer. Endocr Relat Cancer 26(10):R553–R566PubMedCrossRef
6.
Spencer C, LoPresti J, Fatemi S (2014) How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies. Curr Opin Endocrinol Diabetes Obes 21(5):394–404PubMedPubMedCentralCrossRef
7.
8.
Wong H, Wong KP, Yau T, Tang V, Leung R, Chiu J et al (2012) Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation? Ann Surg Oncol 19(11):3479–3485PubMedPubMedCentralCrossRef
9.
Miyauchi A, Kudo T, Miya A, Kobayashi K, Ito Y, Takamura Y et al (2011) Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. Thyroid 21(7):707–716PubMedCrossRef
10.
Tufano RP, Clayman G, Heller KS, Inabnet WB, Kebebew E, Shaha A et al (2015) Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance. Thyroid Off J Am Thyroid Assoc 25(1):15–27CrossRef
11.
Gray JL, Singh G, Uttley L, Balasubramanian SP (2018) Routine thyroglobulin, neck ultrasound and physical examination in the routine follow up of patients with differentiated thyroid cancer—where is the evidence? Endocrine 62(1):26–33PubMedPubMedCentralCrossRef
12.
Ringel MD, Nabhan F (2013) Approach to follow-up of the patient with differentiated thyroid cancer and positive anti-thyroglobulin antibodies. J Clin Endocrinol Metab 98(8):3104–3110PubMedPubMedCentralCrossRef
13.
Spencer CA (2011) Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab 96(12):3615–3627PubMedCrossRef
14.
Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH et al (2011) Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology 260(3):892–899PubMedCrossRef
15.
Salmaslioğlu A, Erbil Y, Dural C, Işsever H, Kapran Y, Ozarmağan S et al (2008) Predictive value of sonographic features in preoperative evaluation of malignant thyroid nodules in a multinodular goiter. World J Surg 32(9):1948–1954PubMedCrossRef
16.
Leenhardt L, Erdogan MF, Hegedus L, Mandel SJ, Paschke R, Rago T et al (2013) 2013 European Thyroid Association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid J 2(3):147–159PubMedPubMedCentralCrossRef
17.
Lamartina L, Deandreis D, Durante C, Filetti S (2016) Endocrine tumours: imaging in the follow-up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approach. Eur J Endocrinol 175(5):R185-202PubMedCrossRef
18.
Scharpf J, Tuttle M, Wong R, Ridge D, Smith R, Hartl D et al (2016) Comprehensive management of recurrent thyroid cancer: an American Head and Neck Society consensus statement. Head Neck 38(12):1862–1869PubMedCrossRef
19.
Miah CF, Zaman JA, Simon M, Davidov T, Trooskin SZ. The utility of lymph node mapping sonogram and thyroglobulin surveillance in post thyroidectomy papillary thyroid cancer patients. Surgery. 2014;156(6):1491–6; discussion 1496–1497.
20.
Maxon HR (1999) Detection of residual and recurrent thyroid cancer by radionuclide imaging. Thyroid 9(5):443–446PubMedCrossRef
21.
Shindo ML, Caruana SM, Kandil E, McCaffrey JC, Orloff LA, Porterfield JR et al (2014) management of invasive well-differentiated thyroid cancer: an American Head and Neck Society consensus statement. AHNS consensus statement Head Neck 36(10):1379–1390PubMed
22.
Salvatori M, Biondi B, Rufini V (2015) Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up. Eur J Endocrinol 173(3):R115-130PubMedCrossRef
23.
Gulec S (2017) The art and science of thyroid surgery in the age of genomics: 100 years after Theodor Kocher. Mol Imaging Radionucl Ther 26(Suppl 1):1–9PubMedPubMedCentralCrossRef
24.
Gourgiotis S, Moustafellos P, Dimopoulos N, Papaxoinis G, Baratsis S, Hadjiyannakis E (2006) Inadvertent parathyroidectomy during thyroid surgery: the incidence of a complication of thyroidectomy. Langenbecks Arch Surg 391(6):557–560PubMedCrossRef
25.
Lee NJ, Blakey JD, Bhuta S, Calcaterra TC (1999) Unintentional parathyroidectomy during thyroidectomy. Laryngoscope 109(8):1238–1240PubMedCrossRef
26.
Lin DT, Patel SG, Shaha AR, Singh B, Shah JP (2002) Incidence of inadvertent parathyroid removal during thyroidectomy. Laryngoscope 112(4):608–611PubMedCrossRef
27.
Ondik MP, McGinn J, Ruggiero F, Goldenberg D (2010) Unintentional parathyroidectomy and hypoparathyroidism in secondary central compartment surgery for thyroid cancer. Head & Neck: Journal for the Sciences and Specialties of the Head and Neck (4):462–6
28.
Manouras A, Markogiannakis H, Lagoudianakis E, Antonakis P, Genetzakis M, Papadima A et al (2008) Unintentional parathyroidectomy during total thyroidectomy. Head Neck 30(4):497–502PubMedCrossRef
29.
Gonçalves Filho J, Zafereo ME, Ahmad FI, Nixon IJ, Shaha AR, Vander Poorten V et al (2018) decision making for the central compartment in differentiated thyroid cancer. Eur J Surg Oncol 44(11):1671–1678PubMedCrossRef
30.
Lo CY, Lam KY (2001) Routine parathyroid autotransplantation during thyroidectomy. Surgery 129(3):318–323PubMedCrossRef
31.
Nishida T, Nakao K, Hamaji M, Kamiike W, Kurozumi K, Matsuda H (1997) Preservation of recurrent laryngeal nerve invaded by differentiated thyroid cancer. Ann Surg 226(1):85–91PubMedPubMedCentralCrossRef
32.
Falk SA, McCaffrey TV (1995) Management of the recurrent laryngeal nerve in suspected and proven thyroid cancer. Otolaryngol-Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg 113(1):42–48CrossRef
33.
Chiang F-Y, Wang L-F, Huang Y-F, Lee K-W, Kuo W-R (2005) Recurrent laryngeal nerve palsy after thyroidectomy with routine identification of the recurrent laryngeal nerve. Surgery 137(3):342–347PubMedCrossRef
34.
Wu C-W, Dionigi G, Barczynski M, Chiang F-Y, Dralle H, Schneider R et al (2018) International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic data. Laryngoscope 128(Suppl 3):S18-27PubMedCrossRef
35.
Hermann M, Hellebart C, Freissmuth M (2004) Neuromonitoring in thyroid surgery: prospective evaluation of intraoperative electrophysiological responses for the prediction of recurrent laryngeal nerve injury. Ann Surg 240(1):9–17PubMedPubMedCentralCrossRef
36.
Timon CI, Rafferty M (1999) Nerve monitoring in thyroid surgery: is it worthwhile? Clin Otolaryngol Allied Sci 24(6):487–490PubMedCrossRef
37.
Pisanu A, Porceddu G, Podda M, Cois A, Uccheddu A (2014) Systematic review with meta-analysis of studies comparing intraoperative neuromonitoring of recurrent laryngeal nerves versus visualization alone during thyroidectomy. J Surg Res 188(1):152–161PubMedCrossRef
38.
Wu S-Y, Shen H-Y, Duh Q-Y, Hsieh C-B, Yu J-C, Shih M-L (2018) Routine intraoperative neuromonitoring of the recurrent laryngeal nerve to facilitate complete resection and ensure safety in thyroid cancer surgery. Am Surg Atlanta 84(12):1882–1888
39.
40.
Higgins TS, Gupta R, Ketcham AS, Sataloff RT, Wadsworth JT, Sinacori JT (2011) Recurrent laryngeal nerve monitoring versus identification alone on post-thyroidectomy true vocal fold palsy: a meta-analysis. Laryngoscope 121(5):1009–1017PubMedCrossRef
41.
Sanabria A, Silver CE, Suárez C, Shaha A, Khafif A, Owen RP et al (2013) Neuromonitoring of the laryngeal nerves in thyroid surgery: a critical appraisal of the literature. Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol - Head Neck Surg 270(9):2383–2395
42.
Zheng S, Xu Z, Wei Y, Zeng M, He J (2013) Effect of intraoperative neuromonitoring on recurrent laryngeal nerve palsy rates after thyroid surgery–a meta-analysis. J Formos Med Assoc Taiwan Yi Zhi 112(8):463–472PubMedCrossRef
43.
Rulli F, Ambrogi V, Dionigi G, Amirhassankhani S, Mineo TC, Ottaviani F et al (2014) Meta-analysis of recurrent laryngeal nerve injury in thyroid surgery with or without intraoperative nerve monitoring. Acta Otorhinolaryngol Ital Organo Uff Della Soc Ital Otorinolaringol E Chir Cerv-facc 34(4):223–229
44.
Malik R, Linos D (2016) Intraoperative neuromonitoring in thyroid surgery: a systematic review. World J Surg 40(8):2051–2058PubMedCrossRef
45.
Lombardi CP, Carnassale G, Damiani G, Acampora A, Raffaelli M, De Crea C et al (2016) “The final countdown”: is intraoperative, intermittent neuromonitoring really useful in preventing permanent nerve palsy? Evidence from a meta-analysis Surgery 160(6):1693–1706PubMed
46.
Yang S, Zhou L, Lu Z, Ma B, Ji Q, Wang Y (2017) Systematic review with meta-analysis of intraoperative neuromonitoring during thyroidectomy. Int J Surg Lond Engl 39:104–113CrossRef
47.
Scheumann GF, Seeliger H, Musholt TJ, Gimm O, Wegener G, Dralle H et al (1996) Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg Acta Chir 162(9):677–684
48.
Erbil Y, Bozbora A, Ademoglu E, Salmaslioglu A, Ozarmagan S (2008) Is timing important in thyroid re-operation? J Otolaryngol - Head Neck Surg J Oto-Rhino-Laryngol Chir Cervico-Faciale 37(1):56–64
49.
Glockzin G, Hornung M, Kienle K, Thelen K, Boin M, Schreyer AG et al (2012) Completion thyroidectomy: effect of timing on clinical complications and oncologic outcome in patients with differentiated thyroid cancer. World J Surg 36(5):1168–1173PubMedCrossRef
50.
Tan MP, Agarwal G, Reeve TS, Barraclough BH, Delbridge LW (2002) Impact of timing on completion thyroidectomy for thyroid cancer. Br J Surg 89(6):802–804PubMedCrossRef
51.
Walgenbach S, Junginger T (2002) Is the timing of completion thyroidectomy for differentiated thyroid carcinoma prognostic significant? Zentralbl Chir 127(5):435–438PubMedCrossRef
52.
Salari B, Hammon RJ, Kamani D, Randolph GW (2017) Staged surgery for advanced thyroid cancers: safety and oncologic outcomes of neural monitored surgery. Otolaryngol-Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg 156(5):816–821CrossRef
53.
Schneider R, Sekulla C, Machens A, Lorenz K, Thanh PN, Dralle H (2016) Dynamics of loss and recovery of the nerve monitoring signal during thyroidectomy predict early post-operative vocal fold function. Head Neck 38(Suppl 1):E1144-1151PubMedCrossRef
54.
Périé S, Aït-Mansour A, Devos M, Sonji G, Baujat B, St Guily JL (2013) Value of recurrent laryngeal nerve monitoring in the operative strategy during total thyroidectomy and parathyroidectomy. Eur Ann Otorhinolaryngol Head Neck Dis 130(3):131–136PubMedCrossRef
55.
Al-Saif O, Farrar WB, Bloomston M, Porter K, Ringel MD, Kloos RT (2010) Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab 95(5):2187–2194PubMedPubMedCentralCrossRef
56.
Palme CE, Waseem Z, Raza SN, Eski S, Walfish P, Freeman JL (2004) Management and outcome of recurrent well-differentiated thyroid carcinoma. Arch Otolaryngol Head Neck Surg 130(7):819–824PubMedCrossRef
Metadata
Title
Revision Thyroid Surgery
Authors
Karthik Nagaraja Rao
Satish Satpute
Nitin M. Nagarkar
Ambesh Singh
Publication date
01-03-2022
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology / Issue 1/2022
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-021-01467-6

Other articles of this Issue 1/2022

Indian Journal of Surgical Oncology 1/2022 Go to the issue

Review Article

Nuances in the Surgical Management of Thyroid Cancer

Original Article

Revisiting Combination Chemotherapy as a Single Modality Palliative Therapy for Advanced Anaplastic Thyroid Carcinoma—a Single Institution Experience

Original Article

Time to Revisit a Low-Cost Alternative? Palpation Assessment Nerve Monitoring (PANM) for Recurrent Laryngeal Nerve to Predict Postoperative Vocal Cord Function—a Validation Study Using an In-House Neuromonitoring Device

Review Article

Retro-sternal Goitre: an Overview

Original Article

Development of a Low-cost NGS Test for the Evaluation of Thyroid Nodules

Original Article

Outcome of 18f-Fluorodeoxyglucose Positron Emission Tomography (PET)-Directed Resections in Differentiated Thyroid Carcinoma (DTC): Experience in a Developing Country